List of bibliographic references indexed by symptoms
Number of relevant bibliographic references: 31.
[0-20] [
0 - 20][
0 - 31][
20-30][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000208 (2020) |
Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie] | Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration |
| 000329 (2020) |
David R. Goldsmith ; Mark Hyman Rapaport | Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits |
| 000373 (2020) |
Hongzhuan Xuan [République populaire de Chine] ; Aiqun Ou ; Shengyu Hao ; Jiajun Shi ; Xiaolu Jin [République populaire de Chine] | Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota |
| 000D88 (2019) |
Yingwen Hu [États-Unis] ; Bingbing Wang [États-Unis] ; Jiayin Shen [États-Unis] ; Stewart A. Low [États-Unis] ; Karson S. Putt [États-Unis] ; Hans W. M. Niessen [Pays-Bas] ; Eric L. Matteson [États-Unis] ; Linda Murphy [États-Unis] ; Clemens Ruppert [Allemagne] ; Gerrit Jansen [Pays-Bas] ; Stephen J. Oliver [États-Unis] ; Yang Feng [États-Unis] ; Dimiter S. Dimitrov [États-Unis] ; Cheryl Nickerson-Nutter [États-Unis] ; Philip S. Low [États-Unis] | Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis |
| 001055 (2019) |
James Brock | 41. A common rheumatology referral of vague constitutional symptoms and raised inflammatory markers |
| 001056 (2019) |
Ursula Laverty ; Michelle Mchenry | 40. A case of large vessel vasculitis presenting with limb claudication symptoms |
| 001115 (2018) |
Rose I. Massolino [Australie] ; Pravin Hissaria [Australie] ; Anita Lee [Australie] ; Susanna M. Proudman [Australie] | Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis. |
| 001158 (2018) |
Aleksei Titov ; Alexey Petukhov ; Alena Staliarova ; Dmitriy Motorin ; Emil Bulatov ; Oleg Shuvalov ; Surinder M. Soond ; Mauro Piacentini [Italie] ; Gerry Melino [Italie] ; Andrey Zaritskey ; Nickolai A. Barlev | The biological basis and clinical symptoms of CAR-T therapy-associated toxicites |
| 001247 (2018) |
Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon] | Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database. |
| 001345 (2018) |
I. Yokoe [Japon] ; H. Kobayashi [Japon] ; Y. Kobayashi [Japon] ; J T Giles [États-Unis] ; K. Yoneyama [Japon] ; N. Kitamura [Japon] ; M. Takei [Japon] | Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms. |
| 001466 (2018) |
Sylvie Vancassel [France] ; Lucile Capuron [France] ; Nathalie Castanon [France] | Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms |
| 001520 (2018) |
Ragy R. Girgis [États-Unis] ; Adam Ciarleglio [États-Unis] ; Tse Choo [États-Unis] ; Gregory Haynes [États-Unis] ; Joan M. Bathon [États-Unis] ; Serge Cremers [États-Unis] ; Joshua T. Kantrowitz [États-Unis] ; Jeffrey A. Lieberman [États-Unis] ; Alan S. Brown [États-Unis] | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia. |
| 001536 (2017) |
Elina Zuelgaray ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France] | Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease: A Case Report |
| 001593 (2017) |
Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France] | Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. |
| 001663 (2017) |
Naoto Azuma [Japon] ; Kiyoshi Matsui [Japon] ; Naoaki Hashimoto [Japon] ; Takahiro Yoshikawa [Japon] ; Hajime Sano [Japon] | Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis. |
| 001767 (2017) |
M. Benucci [Italie] ; A. Damiani ; F. Li Gobbi ; V. Grossi ; M. Infantino ; A. Arena ; M. Manfredi | Jaccoud's arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment. |
| 001B86 (2016) |
Lijun Liu [République populaire de Chine] ; Shengyun Liu [République populaire de Chine] ; Wenjuan Guan [République populaire de Chine] ; Lei Zhang [République populaire de Chine] | Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature. |
| 002301 (2014) |
Hitomi Kobayashi ; Yasuyuki Kobayashi [Oman] ; Jon T. Giles ; Kihei Yoneyama ; Yasuo Nakajima ; Masami Takei | Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. |
| 002307 (2014) |
Sho Mokuda [Japon] ; Masamoto Kanno [Japon] ; Kiyoshi Takasugi [Japon] ; Chikara Okumura [Japon] ; Yuki Ito [Japon] ; Junya Masumoto [Japon] | Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling. |
| 002807 (2013) |
Hiroshi Kawabata [Japon] ; Kazue Takai ; Masaru Kojima ; Naoya Nakamura ; Sadao Aoki ; Shigeo Nakamura ; Tomohiro Kinoshita ; Yasufumi Masaki | Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). |
| 002942 (2013) |
D. Isaacs ; N. Aziz ; J. Tibble ; M. Keller [Royaume-Uni] ; I. Haq [Royaume-Uni] | THU0429 Extra Hepatic Symptoms and Quality of Life before and after Antiviral Treatment in Patients with Hepatitis C |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "symptoms"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "symptoms" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= symptoms
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
